Xalatan and Nasal septum deviation - a phase IV clinical study of FDA data

Summary:

Nasal septum deviation is reported as a side effect among people who take Xalatan (latanoprost), especially for people who are male, 60+ old, also take Prilosec, and have Depression.

The phase IV clinical study analyzes which people have Nasal septum deviation when taking Xalatan. It is created by eHealthMe based on reports of 25,196 people who have side effects when taking Xalatan from the FDA, and is updated regularly.

What is Xalatan?

Xalatan has active ingredients of latanoprost. It is often used in glaucoma. eHealthMe is studying from 25,550 Xalatan users. Check the latest studies of Xalatan.

What is Nasal septum deviation?

Nasal septum deviation (deviated nasal septum) is found to be associated with 475 drugs and 461 conditions by eHealthMe. Check the latest studies of Nasal septum deviation.

On Jul, 15, 2026

25,196 people reported to have side effects when taking Xalatan.
Among them, 16 people (0.06%) have Nasal septum deviation.

Could Xalatan cause Nasal septum deviation?

Among these 16 people:

What is the gender of people who have Nasal septum deviation when taking Xalatan? *

female: 40 %
male: 60 %

What is the age of people who have Nasal septum deviation when taking Xalatan? *

What are other drugs people take besides Xalatan? *

What are other side effects people have besides Nasal septum deviation? *

Joint Pain: 12 people, 75.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 75.00%
Dizziness: 12 people, 75.00%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 11 people, 68.75%
Vision Blurred: 11 people, 68.75%
Pain: 11 people, 68.75%
Fall: 11 people, 68.75%
Osteonecrosis Of Jaw (death of bone of jaw): 11 people, 68.75%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 11 people, 68.75%
Back Pain: 11 people, 68.75%

What are the existing conditions these people have? *

Depression: 11 people, 68.75%
Stable Angina (a constant chest pain): 9 people, 56.25%
Arrhythmias (irregular heartbeat): 9 people, 56.25%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 9 people, 56.25%
Multiple Myeloma (cancer of the plasma cells): 9 people, 56.25%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 18.75%
Thyroid Diseases: 2 people, 12.50%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 12.50%
High Blood Pressure: 2 people, 12.50%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Xalatan and have Nasal septum deviation?

- Check whether Nasal septum deviation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xalatan:

Xalatan (25,550 reports)

Browse all side effects of Xalatan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nasal septum deviation:

Nasal septum deviation (475 drugs)

Browse all the conditions that are associated with Nasal septum deviation:

Nasal septum deviation (461 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on latanoprost (the active ingredients of Xalatan) and Xalatan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.